Diabetes prevention in primary care: a review of lifestyle interventions, screening, and risk reduction


  • Marwah Y. Abdullah Department of Family Medicine, East Jeddah Hospital, Jeddah, Saudi Arabia
  • Emtenan A. Esmael Department of Otolaryngology, Ahad Rafidah General Hospital, Abha, Saudi Arabia
  • Khalid M. Alqahtani Department of Urology, Abha Maternity and Children Hospital, Abha, Saudi Arabia
  • Kholoud H. Qahl Primary Health Care, Ministry of Health, Jeddah, Saudi Arabia
  • Naif A. Alanazi Arar Primary Healthcare Center, Ministry of Health, Arar, Saudi Arabia
  • Hashim W. Alshakhs Endocrine and Diabetes Center, King Fahad Hospital, Al Hofuf, Saudi Arabia
  • Fahad A. Alayyash Khamis Mushait Primary Health Care, Abha, Saudi Arabia
  • Yousef A. Almalki Department of Preventative Medicine, Prince Mansour Military Hospital, Taif, Saudi Arabia
  • Mohammed A. Alharbi Primary Health Care, Second Health Cluster Central Region, Riyadh, Saudi Arabia
  • Ahmed I. Alharbi Employee Clinic, Medical Rehabilitation Hospital, Medina, Saudi Arabia
  • Maram S. Alhamdan Department of Emergency Medicine, King Salman Hospital, Riyadh, Saudi Arabia




Diabetes mellitus, Prevention, Lifestyle modifications, Screening, Risk reduction, Dietary interventions, Physical activity


Diabetes mellitus, a global health crisis, necessitates effective prevention strategies. The prevalence of diabetes is on a relentless rise, leading to severe complications and imposing a substantial societal burden. Diabetes prevention has taken center stage in the public health arena. The imperative to develop effective strategies for preventing diabetes, particularly type 2 diabetes, has never been more apparent. The primary goal of diabetes screening is to identify individuals at risk of developing the disease, particularly type 2 diabetes. This paper explores the multifaceted landscape of diabetes prevention, emphasizing the role of lifestyle modifications, screening, and risk reduction. Lifestyle modifications encompass dietary changes, physical activity, and behavioral adjustments, forming the foundational approach. Screening, with various methods and risk assessment tools, identifies at-risk individuals, allowing for timely interventions. Risk reduction strategies target modifiable factors and are essential for both preventing diabetes onset and mitigating complications. These approaches empower individuals, healthcare professionals, and policymakers to combat diabetes's increasing prevalence and its associated health and economic consequences.


Magliano DJ, Boyko EJ. IDF diabetes atlas. 2022. Available at: https://diabetesatlas.org/idfawp/ resource-files/2021/07/IDF_Atlas_10th_ Edition_2021.pdf. Accessed on 12 July 2023.

Kimpton SLA. Decreasing the Confusion of Diabetes: Focused Education and Management Risk Reduction Strategies Aimed at Decreasing Cardiovascular Risk for Patients with Type 2 Diabetes. National Library of Canada= Bibliothèque nationale du Canada, Ottawa. 2004.

Meetoo D. Diabetes: complications and the economic burden. Br J Healthc Manag. 2014;20(2):60-7.

Walker AF, Graham S, Maple-Brown L, Egede LE, Campbell JA, Walker RJ, et al. Interventions to address global inequity in diabetes: international progress. The Lancet. 2023;402(10397):250-64.

Marrero DG, Ard J, Delamater AM, eragallo-Dittko V, Mayer-Davis EJ, Nwankwo R, et al. Twenty-first century behavioral medicine: a context for empowering clinicians and patients with diabetes: a consensus report. Diabetes Care. 2013;36(2):463.

Schulze MB, Hu FB. Primary prevention of diabetes: what can be done and how much can be prevented? Annu Rev Public Health. 2005;26:445-67.

Alkhatib A, Tsang C, Tiss A, Bahorun T, Arefanian H, Barake R, et al. Functional foods and lifestyle approaches for diabetes prevention and management. Nutrients. 2017;9(12):1310.

Maukonen M, Harald K, Kaartinen NE, Tapanainen H, Albanes D, Eriksson J, et al. Partial substitution of red or processed meat with plant-based foods and the risk of type 2 diabetes. Scientific Rep. 2023;13(1):5874.

Bonsembiante L, Targher G, Maffeis C. Type 2 Diabetes and Dietary Carbohydrate Intake of Adolescents and Young Adults: What Is the Impact of Different Choices? Nutrients. 2021;13(10):3344.

Venn B, Mann J. Cereal grains, legumes and diabetes. Eur J Clin Nutr. 2004;58(11):1443-61.

Ley SH, Hamdy O, Mohan V, Hu FB. Prevention and management of type 2 diabetes: dietary components and nutritional strategies. The Lancet. 2014;383(9933):1999-2007.

Milenkovic T, Bozhinovska N, Macut D, Bjekic-Macut J, Rahelic D, Velija Asimi Z, et al. Mediterranean diet and type 2 diabetes mellitus: a perpetual inspiration for the scientific world. A review. Nutrients. 2021;13(4):1307.

Hosseinpour-Niazi S, Mirmiran P, Hadaegh F, Mahdavi M, Khalili D, Daneshpour MS, et al. Improvement of glycemic indices by a hypocaloric legume-based DASH diet in adults with type 2 diabetes: a randomized controlled trial. Eur J Nutr. 2022;61(6):3037-49.

Mattson MP, Allison DB, Fontana L, Harvie M, Longo VD, Malaisse WJ, et al. Meal frequency and timing in health and disease. Proc Natl Acad Sci U S A. 2014;111(47):16647-53.

Gill JM, Malkova D. Physical activity, fitness and cardiovascular disease risk in adults: interactions with insulin resistance and obesity. Clin Sci. 2006;110(4):409-25.

Borghouts L, Keizer H. Exercise and insulin sensitivity: a review. Int J Sports Med. 2000;21(01):1-12.

Jarvie JL, Pandey A, Ayers CR, McGavock JM, Sénéchal M, Berry JD, et al. Aerobic fitness and adherence to guideline-recommended minimum physical activity among ambulatory patients with type 2 diabetes mellitus. Diabetes Care. 2019;42(7):1333-9.

Strasser B, Pesta D. Resistance training for diabetes prevention and therapy: experimental findings and molecular mechanisms. Biomed Res Int. 2013;805217.

Marcus BH, Forsyth LH. Motivating people to be physically active. 2nd Edition. Human Kinetics. 2008.

Ekoe J-M, Goldenberg R, Katz P, Committee DCCPGE. Screening for diabetes in adults. Canad J Diabetes. 2018;42:S16-9.

Ekoé J-M, Punthakee Z, Ransom T, Prebtani AP, Goldenberg R. Screening for type 1 and type 2 diabetes. Canad J Diabetes. 2013;37:S12-5.

Chung JK-O, Xue H, Pang EW-H, Tam DC-C. Accuracy of fasting plasma glucose and hemoglobin A1c testing for the early detection of diabetes: A pilot study. Front Lab Med. 2017;1(2):76-81.

Mshelia DS, Adamu S, Gali RM. Oral glucose tolerance test (ogtt): Undeniably the first choice investigation of dysglycaemia, reproducibility can be improved. In: Type 2 Diabetes-From Pathophysiology to Cyber Systems. IntechOpen. 2021.

Higgins T. HbA1c for screening and diagnosis of diabetes mellitus. Endocrine. 2013;43(2):266-73.

Lindstrom J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care. 2003;26(3):725-31.

Tankova T, Chakarova N, Atanassova I, Dakovska L. Evaluation of the Finnish Diabetes Risk Score as a screening tool for impaired fasting glucose, impaired glucose tolerance and undetected diabetes. Diabetes Res Clin Pract. 2011;92(1):46-52.

Yun J-S, Ko S-H. Current trends in epidemiology of cardiovascular disease and cardiovascular risk management in type 2 diabetes. Metabolism. 2021;123:154838.

Hu FB. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care. 2011;34(6):1249-57.

Wali JA, Solon-Biet SM, Freire T, Brandon AE. Macronutrient determinants of obesity, insulin resistance and metabolic health. Biology. 2021;10(4):336.

Buysschaert M, Medina JL, Bergman M, Shah A, Lonier J. Prediabetes and associated disorders. Endocrine. 2015;48:371-93.

Budreviciute A, Damiati S, Sabir DK, Onder K, Schuller-Goetzburg P, Plakys G, et al. Management and prevention strategies for non-communicable diseases (NCDs) and their risk factors. Front Public Health. 2020;8:788.

Association AD. 8. Cardiovascular disease and risk management. Diabetes Care. 2016;39(1):S60-71.

Morgan CL, Currie C, Stott N, Smithers M, Butler CC, Peters J. The prevalence of multiple diabetes‐related complications. Diabetic Med. 2000;17(2):146-51.

John S. Complication in diabetic nephropathy. Diabetes Metabolic Syndrome: Clin Res Rev. 2016;10(4):247-9.

von Philipsborn P, Stratil JM, Burns J, Busert LK, Pfadenhauer LM, Polus S, et al. Environmental interventions to reduce the consumption of sugar‐sweetened beverages and their effects on health. Cochrane Database of Syst Rev. 2019;6(6):CD012292.

Phung O, Sood N, Sill B, Coleman C. Oral anti‐diabetic drugs for the prevention of Type 2 diabetes. Diabetic medicine. 2011;28(8):948-64.

Yoshida Y, Simoes EJ. Sugar-sweetened beverage, obesity, and type 2 diabetes in children and adolescents: policies, taxation, and programs. Curr Diabetes Rep. 2018;18:1-10.




How to Cite

Abdullah, M. Y., Esmael, E. A., Alqahtani, K. M., Qahl, K. H., Alanazi, N. A., Alshakhs, H. W., Alayyash, F. A., Almalki, Y. A., Alharbi, M. A., Alharbi, A. I., & Alhamdan, M. S. (2023). Diabetes prevention in primary care: a review of lifestyle interventions, screening, and risk reduction. International Journal Of Community Medicine And Public Health, 10(12), 5061–5066. https://doi.org/10.18203/2394-6040.ijcmph20233551



Review Articles